3//SEC Filing
SYNAGEVA BIOPHARMA CORP 3
Accession 0001571049-15-005382
CIK 0000911326operating
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 5:30 PM ET
Size
6.9 KB
Accession
0001571049-15-005382
Insider Transaction Report
Form 3
ALEXION PHARMACEUTICALS INC
10% Owner
Holdings
- 21,021,124(indirect: Through direct, wholly owned subsidiary (see explanatory note))
Common stock, par value $0.001 per share, of Synageva
Pulsar Merger Sub Inc
10% Owner
Holdings
- 21,021,124(indirect: Through direct, wholly owned subsidiary (see explanatory note))
Common stock, par value $0.001 per share, of Synageva
Documents
Issuer
SYNAGEVA BIOPHARMA CORP
CIK 0000911326
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000911326
Filing Metadata
- Form type
- 3
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 5:30 PM ET
- Size
- 6.9 KB